Fundraising

Product manager Luo Yonghao humorously attributes his fundraising success to relentless public engagement, positive or negative. After the AGI Playground 2025 conference, Luo revealed extensive investments in AR glasses that proved commercially impractical. He also hinted at a software-based launch from his new company, Thin Red Line, sparking anticipation regarding his next venture.

Nepra Foods Inc. announced a non-brokered private placement to raise up to $500,000. The offering involves issuing units at $0.06 each, comprising a common share and a warrant. Funds will be used for working capital. Closing is subject to regulatory approvals. Nepra Foods, a specialist in allergen- and gluten-free food ingredients, aims to strengthen its position in the healthy food market through this financing.

Alvotech, a global biosimilar medicines developer, commenced trading on Nasdaq Stockholm on May 19, 2025, via an oversubscribed SDR offering (441,600 SDRs at SEK 87.51 each, raising SEK 39M). This triple-listing (including Nasdaq Global and Iceland) enhances liquidity and European investor access, while the pending acquisition of Xbrane Biopharma’s R&D operations in Sweden supports scientific expansion. Despite a 10% SDR price discount and added operational complexity, the move aims to strengthen Nordic presence, diversify funding sources, and capitalize on robust biotech investment interest in Europe.